Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
45 hedge funds and large institutions have $8.92M invested in Nymox Pharmaceutical Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 4 closing their positions.
43% more capital invested
Capital invested by funds: $6.25M → $8.92M (+$2.67M)
4% less funds holding
Funds holding: 47 → 45 (-2)
20% less call options, than puts
Call options by funds: $90K | Put options by funds: $112K
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$40K |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
+$38.2K |
| 3 |
WCWM
Willow Creek Wealth Management
Sebastopol,
California
|
+$35.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.5K |
| 5 |
Goldman Sachs
New York
|
+$32.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$256K |
| 2 |
Morgan Stanley
New York
|
-$135K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$66.6K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$50K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$49K |
NYMX Hedge Fund Activity: Q1 2019 in Review
45 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2019, worth a combined $8.92M — up 43% from $6.25M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NYMX and 2 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 12 added.
The largest buyer was State Street, adding an estimated $40K. The largest seller was Susquehanna International Group, cutting an estimated $256K.
- 45 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2019, down from 47 in Q4 2018.
- Funds reported $8.92M of Nymox Pharmaceutical Corp stock for Q1 2019, up 43% quarter-over-quarter.
- 2 funds opened new Nymox Pharmaceutical Corp positions in Q1 2019 and 4 closed out, a net change of -2 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2019 was State Street, an estimated $40K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2019 was Susquehanna International Group, an estimated $256K sold.
Based on aggregated 13F filings for Q1 2019.